Sort
39,280 grants matching “leukemia”
Host factors and etiology of leukemia
$331,525Children'S Hospital Med Ctr (Cincinnati) · R01 · FY2004 · CA
PATHOLOGY AND BIOLOGY OF LEUKEMIA ONCOGENES
$331,518Stanford University · R01 · FY2002 · CA
Project 2 - Targeting IDH-mutant gliomas (Cahill/Kaelin)
$331,503William G Kaelin · Brigham And Women'S Hospital · P50 · FY2019 · CA
Processing and consequences of DNA-protein crosslinks in E. coli
$331,500Kenneth N Kreuzer · Duke University · R01 · FY2009 · GM
TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef
$331,500Shan-Lu Liu · Ohio State University · R01 · FY2020 · AI
TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef
$331,500Shan-Lu Liu · Ohio State University · R01 · FY2019 · AI
TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef
$331,500Shan-Lu Liu · Ohio State University · R01 · FY2018 · GM
TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef
$331,500Shan-Lu Liu · Ohio State University · R01 · FY2021 · AI
Increasing the Selectivity of Hybrid Mass Spectrometry using Multidimensional Ion Mobility Spectrometry
$331,496Matthew Francis Bush · University Of Washington · R01 · FY2019 · GM
The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis
$331,433Ulf Klein · Columbia University Health Sciences · R01 · FY2016 · CA
HTLV-1 Particle Analysis and Gag Interactions
$331,409Louis M Mansky · University Of Minnesota · R01 · FY2012 · GM
Drug-Free Macromolecular Therapeutics
$331,402Jindrich N. Kopecek · University Of Utah · R01 · FY2024 · CA
A Leukemia Cell-Specific Coiled-Coil Protein for Treatment of Chronic Myeloid Leukemia
$331,402Carol S Lim · University Of Utah · R01 · FY2024 · CA
Pathology
$331,401Sherif S Farag · Ohio State University · P01 · FY2009 · CA
Myeloid cell function in muscle injury and repair
$331,369James G Tidball · University Of California Los Angeles · R01 · FY2007 · AR
Improving therapy of glioblastoma multiforme by enhancing therapeutic drug delive
$331,320Michael R McDevitt · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Project 5: Transplant Conditioning for MDS and AML with Biological Agents
$331,313Judith Anne Shizuru · Stanford University · P01 · FY2020 · CA
Molecular Mechanism of Leukemogenesis Involving AML1-ETO
$331,313Dong-Er Zhang · University Of California, San Diego · R01 · FY2018 · CA
Molecular Mechanism of Leukemogenesis Involving AML1-ETO
$331,313Dong-Er Zhang · University Of California, San Diego · R01 · FY2016 · CA
Molecular Mechanism of Leukemogenesis Involving AML1-ETO
$331,313Dong-Er Zhang · University Of California, San Diego · R01 · FY2017 · CA
Molecular Mechanism of Leukemogenesis Involving AML1-ETO
$331,313Dong-Er Zhang · University Of California, San Diego · R01 · FY2015 · CA
Genomics of AML Clonality
$331,298Timothy J Ley · Washington University · P01 · FY2016 · CA
The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis
$331,240Ulf Klein · Columbia University Health Sciences · R01 · FY2015 · CA
Function of MEF in Hematopoietic Cells
$331,216Sloan-Kettering Institute For Cancer Res · R01 · FY2005 · DK
Function of MEF in Hematopoietic Cells
$331,216Sloan-Kettering Institute For Cancer Res · R01 · FY2004 · DK